The Movement Disorder Spectrum of ATP1A3 ‐Related Disorders: Cross‐Sectional Analysis and Video Archive of 88 Patients
Movement Disorders · 2026-05 · 41 (5) · 1268-1284
DOI: 10.1002/mds.70227 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Movement Disorders, online erschienen am 18.03.2026. Verfasst von Katerina Bernardi und 29 weiteren Autor:innen. Beteiligte Einrichtung: Movement Disorders Program, Department of Neurology & F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Mas…. Hauptthemen laut MEDLINE: Sodium-Potassium-Exchanging ATPase, Movement Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, Dystonia Medical Research Foundation, The Movement Disorders Society.
Abstract (Originalsprache)
Background
ATP1A3 ‐related disorders are characterized by genetic heterogeneity and phenotypic pleiotropy, posing significant challenges for classification. Although canonical phenotypes have traditionally guided decision‐making, increasing evidence highlights their limitations in capturing the clinical complexity.
Objective
The aims of this study were to characterize movement disorders, paroxysmal features, and genotype–phenotype relationships; to build a curated video archive; and to assess alignment with canonical phenotypes.
Methods
This is an observational study of 88 individuals with pathogenic or likely pathogenic variants in ATP1A3 who were evaluated in specialized movement disorders programs.
Results
Age at last clinical follow‐up ranged from 0.1 to 63 years; 80.7% were pediatric patients. Chronic movement disorders were present in 68 of 88 individuals (75%); most had two or more coexisting phenomenologies. Dystonia was most common (47/88, 53%), followed by spasticity (28/88, 32%) and ataxia (28/92, 32%). Paroxysmal events occurred in 78 of 88 (88%) patients, including dystonic spells (45/78, 58%), abnormal eye movements (39/78, 50%), and hemiplegic episodes (37/78, 47%). Common comorbidities included epilepsy (21/88, 24%), cognitive impairment (41/88, 47%), and neuropsychiatric disorders. Only 22 of 88 (25%) fulfilled criteria for a single canonical phenotype; 28 of 88 (32%) met canonical criteria plus additional features, 18 of 88 (20%) satisfied criteria for ≥2 canonical phenotypes, and 20 of 88 (23%) fit no canonical category. We identified 43 distinct ATP1A3 variants; recurrent variants (eg, p.Arg756His, p.Asp801Asn, p.Glu818Lys) showed variable expressivity across categories.
Conclusions
The extensive clinical heterogeneity in ATP1A3 ‐related disorders challenges rigid phenotypic classifications. The predominance of patients with overlapping or atypical features supports a shift toward flexible, symptom‐based clinical approaches rather than strict reliance on canonical phenotype recognition. © 2026 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Movement Disorders Program, Department of Neurology & F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
- Pediatric Neurology Research Group, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital, Athens, Greece.
- Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
- Department of Pediatrics, Division of Pediatric Neurology, Norton Children's Medical Group, University of Louisville, Louisville, Kentucky, USA.
ORCID-Profile: Katerina Bernardi, Anna Zhou, Kathryn Yang, Joshua Rong, Vicente Quiroz, Julian E Alecu, Habibah A P Agianda, Henri J D Schmidt, Amy Tam, Natalia Espasandin-Hueter, Alfons Macaya, Tamara Pringsheim, Margaret Means, Joanna Blackburn, Alonso Zea Vera, Leonie Felicia Becker, Norbert Brüggemann, Alexander Münchau, Yury Seliverstov, Lindsey Vogt, Carolina Gorodetsky, Daniel G Calame, Lifang Dai, Changhong Ding, Darius Ebrahimi-Fakhari
Förderung
- NINDS NIH HHS
- Dystonia Medical Research Foundation
- The Movement Disorders Society
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Bernardi, K., Zhou, A., Yang, K., Rong, J., Quiroz, V., Alecu, J. E., Agianda, H. A. P., Schmidt, H. J. D., Tam, A., Carty, S., Espasandin-Hueter, N., Macaya, A., Stamelou, M., Pringsheim, T., Means, M., Lakhotia, A., Blackburn, J., Zea Vera, A., Becker, L. F., …, & Ebrahimi-Fakhari, D. (2026). The Movement Disorder Spectrum of ATP1A3 ‐Related Disorders: Cross‐Sectional Analysis and Video Archive of 88 Patients. Movement Disorders, 41(5), 1268-1284. https://doi.org/10.1002/mds.70227
Vancouver
Bernardi K, Zhou A, Yang K, Rong J, Quiroz V, Alecu JE, et al. The Movement Disorder Spectrum of ATP1A3 ‐Related Disorders: Cross‐Sectional Analysis and Video Archive of 88 Patients. Movement Disorders. 2026;41(5):1268-1284. doi:10.1002/mds.70227
BibTeX
@article{Bernardi2026,
author = {Bernardi, Katerina and Zhou, Anna and Yang, Kathryn and Rong, Joshua and Quiroz, Vicente and Alecu, Julian E and Agianda, Habibah A P and Schmidt, Henri J D and Tam, Amy and Carty, Siofra and Espasandin-Hueter, Natalia and Macaya, Alfons and Stamelou, Maria and Pringsheim, Tamara and Means, Margaret and Lakhotia, Arpita and Blackburn, Joanna and Zea Vera, Alonso and Becker, Leonie Felicia and Brüggemann, Norbert and Münchau, Alexander and Seliverstov, Yury and Vogt, Lindsey and Gorodetsky, Carolina and Levine, Jesse M and Runco, Alyssa D and Calame, Daniel G and Dai, Lifang and Ding, Changhong and Ebrahimi-Fakhari, Darius},
title = {The Movement Disorder Spectrum of ATP1A3 ‐Related Disorders: Cross‐Sectional Analysis and Video Archive of 88 Patients},
journal = {Movement Disorders},
year = {2026},
volume = {41},
number = {5},
pages = {1268--1284},
doi = {10.1002/mds.70227}
}
EUVIMED